Home > Insider Trading > Filing (0001209191-14-062661)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1496671	Calithera Biosciences Inc.	CALA	Pharmaceutical Preparations (2834)	272366329

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1270734	Deepika Pakianathan	C/O Delphi Ventures, 3000 Sand Hill Road, Bldg. 1, Suite 135 Menlo Park CA 94025		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-10-07	1,908,073	$0.00	1,908,073	No	4	C	Indirect	Delphi Ventures VIII, L.P.
Common Stock	Acquisiton	2014-10-07	18,629	$0.00	18,629	No	4	C	Indirect	Delphi BioInvestments VIII, L.P.
Common Stock	Acquisiton	2014-10-07	495,165	$10.00	2,403,238	No	4	P	Indirect	Delphi Ventures VIII, L.P.
Common Stock	Acquisiton	2014-10-07	4,835	$10.00	23,464	No	4	P	Indirect	Delphi BioInvestments VIII, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	Delphi Ventures VIII, L.P.
No	4	C	Indirect	Delphi BioInvestments VIII, L.P.
No	4	P	Indirect	Delphi Ventures VIII, L.P.
No	4	P	Indirect	Delphi BioInvestments VIII, L.P.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Acquisiton	2014-10-07	6,808	$0.00	6,808	$0.00
Common Stock	Series A Preferred Stock	Acquisiton	2014-10-07	66	$0.00	66	$0.00
Common Stock	Series B Preferred Stock	Acquisiton	2014-10-07	415,128	$0.00	415,128	$0.00
Common Stock	Series B Preferred Stock	Acquisiton	2014-10-07	4,053	$0.00	4,053	$0.00
Common Stock	Series C Preferred Stock	Acquisiton	2014-10-07	740,312	$0.00	740,312	$0.00
Common Stock	Series C Preferred Stock	Acquisiton	2014-10-07	7,228	$0.00	7,228	$0.00
Common Stock	Series D Preferred Stock	Acquisiton	2014-10-07	745,825	$0.00	745,825	$0.00
Common Stock	Series D Preferred Stock	Acquisiton	2014-10-07	7,282	$0.00	7,282	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

The preferred stock automatically converted into Common Stock on a one-for-one basis immediately upon the consummation of Issuer's initial public offering of Common Stock and had no expiration date.
The securities are directly held as follows: 2,403,238 shares by Delphi Ventures VIII, L.P. ("DV VIII") and 23,464 shares held by Delphi BioInvestments VIII, L.P. ("DBI VIII" and together with DV VIII, the "Delphi VIII Funds"). Delphi Management Partners VIII, L.L.C. ("DMP VIII") is the general partner of each of DV VIII and DBI VIII and may be deemed to have sole voting and dispositive power over the securities held by the Delphi VIII Funds. The Reporting Person is a managing member of DMP VIII and may be deemed to share voting and dispositive power over the securities held by the Delphi VIII Funds. The Reporting Person disclaims beneficial ownership of the securities held by Delphi VIII Funds, except to the extent of any pecuniary interest therein.